• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABAXIS, INC. PICCOLO COMPREHENSIVE METABOLIC PANEL; PICCOLO ROTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABAXIS, INC. PICCOLO COMPREHENSIVE METABOLIC PANEL; PICCOLO ROTOR Back to Search Results
Model Number 400-0028
Device Problem High Readings (2459)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
This is a report from a laboratory healthcare professional involving the piccolo xpress analyzer and the comprehensive metabolic panel (cmp) part# 400-0028.The laboratory health professional reported unexpected high creatinine (cre) test results with the following details: this laboratory healthcare professional called initially on (b)(6) 2022 and called back on (b)(6) 2022 to report case details.It is unknown when the samples were run in (b)(6) 2022.(b)(6) 2022 - unknown time - blood was drawn from the patient and analyzed (whole blood) using the piccolo xpress analyzer sn# (b)(4) and (cmp), rotor lot #2173ab1.Results: cre - 4.4 mg/dl (range: 0.6-1.2 mg/dl).The patient was treated for appendicitis based on the clinical signs and symptoms presented (the exact clinical signs and symptoms were not reported).(b)(6) 2022 - 1 hour later- an add-on test- was ordered.The initial sample (whole blood) was analyzed on a different analyzer - piccolo xpress analyzer sn# (b)(4) and a metlyte-8 metabolic panel part # 400-0023, rotor lot #1283ab5.Results: cre - 0.7 mg/dl (range: 0.6-1.2 mg/dl).The piccolo xpress analyzer results were not used to treat or diagnose the patient.The patient was not impacted and the analyzer results did not contribute to any further diagnosis, treatment, illness, or injury.The reporter was concerned about the results obtained from the piccolo xpress analyzer sn# (b)(4) with cmp part # 400- 0028, lot # 2173ab1.A return merchandise authorization (rma) was initiated on 5july2022 for the unused panels.The unused panels were received on 01august2022 for further investigation.A replacement was sent to the customer.The reporter has chosen not to return the analyzer for investigation.A follow-up report will be submitted once the investigation is complete.
 
Event Description
A laboratory healthcare professional reported unexpected high creatinine (cre) results.Per report, a patient was treated based on symptoms of appendicitis - not due to the piccolo xpress analyzer results.
 
Manufacturer Narrative
07nov2022: the quality assurance investigation was complete.Manufacturing investigation response: the clinic observed a high creatinine (cre) result while running whole blood on the comprehensive metabolic panel ( cmp) lot 2173ab1 compared to a rerun of the same sample on a separate rotor and analyzer approximately one hour later 4.4mg/dl versus 0.7 mg/dl respectively (reference range 0.6-1.2 mg/dl).The patient arrived at the clinic with appendicitis and was sent to the er for treatment.The patient was not treated based on the piccolo cre result.The clinic ran controls on lot 2173ab1 on 01 jul 2022 and confirmed the unit "passed qc" but did not provide the results to the technical support representative (tsr) the tsr requested that the clinic return the remaining boxes of the cmp rotor lot#2173ab1 for investigation.Product assurance (pa) tested the customers returned unused rotors and could not confirm high cre.All results at all levels were within range near the target.The initial cre result is likely an outlier due to random variation.A review of the batch record was completed and confirmed lot 2173ab1 met all manufacturing release criteria.A review of the complaint data showed that there were only 2 rotors from this lot reported for high cre out of 8,850 rotors shipped for a complaint rate of (b)(4).There was no reported patient impact and no observed trend for high cre over the last 12 months ending july 2022.This complaint cannot be substantiated.No further action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PICCOLO COMPREHENSIVE METABOLIC PANEL
Type of Device
PICCOLO ROTOR
Manufacturer (Section D)
ABAXIS, INC.
3240 whipple rd
union city CA 94587
Manufacturer (Section G)
ABAXIS
3240 whipple rd
union city CA 94587
Manufacturer Contact
tracy morton
3240 whipple rd
union city, CA 94587
MDR Report Key15854127
MDR Text Key305246661
Report Number2939693-2022-00005
Device Sequence Number1
Product Code CGX
UDI-Device IdentifierEABA40000281
UDI-Public+EABA40000281/$$72173AB1/14D20230420D+
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K942782
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Replace
Type of Report Initial,Followup,Followup
Report Date 01/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/04/2023
Device Model Number400-0028
Device Catalogue Number400-0028
Device Lot Number2173AB1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/05/2022
Initial Date FDA Received11/23/2022
Supplement Dates Manufacturer Received07/05/2022
07/05/2022
Supplement Dates FDA Received11/23/2022
01/31/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
-
-